Following this recommendation, we here demonstrate the value of CRISPR/Cas9 genome editing in modeling hereditary and sporadic CCM disease in vitro, add VWF to the growing list of molecules involved in CCM pathogenesis, and support the hypothesis that a local hemostatic imbalance contributes to thrombosis and hemorrhage in CCMs. This evidence concerns the gene VWF and cerebral cavernous malformation.